Joint Formulary & PAD

Co-dydramol 20/500 - Pain

You are here : Home > Formulary Search > Co-dydramol 20/500 - Pain

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :
Important
Fixed combinations are less preferred. The MHRA advises when prescribing dihydrocodeine with paracetamol, the tablet strength and dose must be clearly indicated

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Co-dydramol 20/500
Indication :
Pain
Group Name :
Keywords :
Dihydrocodeine with paracetamol, non-opioid analgesia, analgesics, compound analgesics
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Pain
Supporting Documents :
0

Committee Recommendations (1)

06 Mar 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Co-dydramol 20/500 is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Pain .